Nordson Corporation · NDSN · FY2025 Q2 · Calendar Q2 2025

Nordson: ATS Strength Offsets Industrial and Destocking Risks

The supplied analysis is constructive but not unqualified: ATS demand, Atrion, pricing, and operational execution support the outlook, while industrial softness, medical destocking, and lumpy demand are meaningful offsets.

Reported After market closeNASDAQIndustrials $18.62B market cap
80quality score

Earnings scorecard

Reported versus consensus
Reported EPS — Consensus $2.36
EPS surprise — Reported versus consensus
Reported revenue — Consensus $671.4M
Revenue surprise — Reported versus consensus

Market reaction

event-close to next-session close
Stock move +6.8% Event window
SPY move +0.4% Same window
Abnormal move +6.4% Stock minus SPY
Volume 2.8× Versus trailing sessions
Subsequent drift +2.9% Up to 20 sessions
NDSNSPY benchmark

Ask FN2 about NDSN FY2025 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior analysis, the current analysis shows stronger reported sales momentum and a clearer contribution from ATS and Atrion, while industrial weakness and medical destocking remain unresolved.

Guidance delta

Management maintained its outlook; the supplied analysis describes next-quarter guidance as aligned with the full-year view.

Key takeaways

  • Management described stronger sales and profitability, led by Advanced Technology Solutions and Atrion.
  • Industrial systems remained weak amid automotive softness, while medical demand continued to reflect destocking.
  • The supplied analysis points to maintained guidance, disciplined capital deployment, and limited direct tariff exposure.

Management priorities

  • Complete the South Carolina industrial coatings plant and expand India manufacturing capacity.
  • Integrate Atrion and CyberOptics-related products while maintaining disciplined capital deployment.
  • Use pricing and operational actions to protect margins in weaker industrial markets.

Follow NDSN with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
NDSN REVENUE earnings history estimate and actual scatter chart 9 reported fiscal quarters and 2 future estimate-only quarters. Q1 '24 estimate $630M Q1 '24 actual $633M, beat Q2 '24 estimate $661M Q2 '24 actual $651M, miss Q3 '24 estimate $657M Q3 '24 actual $662M, beat Q3 '25 estimate $724M Q3 '25 actual $742M, beat Q4 '25 estimate $761M Q4 '25 actual $752M, miss Q1 '26 estimate $653M Q1 '26 actual $669M, beat Q2 '26 estimate $729M Q2 '26 actual $741M, beat Q3 '26 estimate $779M Q3 '26 actual $818M, beat Q4 '26 estimate $829M Q1 '27 estimate $708M
Show 1 more >

Analyst Consensus ?

ConsensusBuy20 ratings
Bullish1365.0%
Neutral735.0%
Bearish00.0%

Analyst 52W Price Targets

$327.69Current
$240Low
$305.33Average
$375High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
DA Davidson Buy BuyMaintainAug 24, 2026
Oppenheimer Outperform OutperformMaintainAug 21, 2026
Baird Neutral NeutralMaintainAug 21, 2026
Keybanc Overweight OverweightMaintainAug 20, 2026
BNP Paribas Neutral NeutralMaintainMay 22, 2026
Show 15 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $327.69. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Industrial Alliance SecuritiesAnalyst unavailable$375$332.21 +14.4%Aug 24, 2026
OppenheimerAnalyst unavailable$370$335.74 +12.9%Aug 21, 2026
Robert W. BairdMichael Halloran$351$334.7 +7.1%Aug 21, 2026
KeyBancAnalyst unavailable$360$309.92 +9.9%Aug 20, 2026
OppenheimerAnalyst unavailable$335$287.66 +2.2%May 29, 2026
See 24 more

Track every rating change on NDSN the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment.…

Historical context

All NDSN earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the NDSN recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2025-05-14T00:02:31.936144+00:00
  3. Polygon adjusted daily market bars · 2026-10-07T23:30:46.086529+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-07T23:30:46.083416+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-07. For educational purposes only; not investment advice.